argenx SE (EBR: ARGX)
467.40
+0.30 (0.06%)
Sep 4, 2024, 4:17 PM CET
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
€1,349,236
Profits / Employee
€166,128
Market Cap
27.93B
Employees Chart
argenx SE News
- 7 days ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Argenx raised to Overweight at Barclays on long-term prospects - Seeking Alpha
- 5 weeks ago - argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update - GlobeNewsWire
- 6 weeks ago - argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 - GlobeNewsWire
- 7 weeks ago - argenx and Zai Lab Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China - GlobeNewsWire
- 7 weeks ago - Zai Lab and argenx Announce Approval of Efgartigimod Alfa Injection (Subcutaneous Injection) for Generalized Myasthenia Gravis in China - Business Wire
- 2 months ago - argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting - GlobeNewsWire
- 2 months ago - Why Is European Drugmaker Argenx Stock Trading Higher On Monday? - Benzinga